Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.04M Sell
7,816
-153
-2% -$39.2K 0.83% 41
2026
Q2
$2.01M Sell
7,969
-216
-3% -$46.5K 0.77% 50
2026
Q1
$1.78M Hold
8,185
– – 0.75% 52
2025
Q4
$1.87M Sell
8,185
-133
-2% -$30.3K 0.72% 48
2025
Q3
$1.93M Hold
8,318
– – 0.71% 50
2025
Q2
$1.54M Hold
8,318
– – 0.6% 53
2025
Q1
$1.74M Hold
8,318
– – 0.48% 55
2024
Q4
$1.47M Buy
+8,318
New +$1.53M 0.41% 56

Other funds holding ABBV

InvesTrust's ABBV Position: Q3 2026 in Review

InvesTrust reduced its AbbVie (ABBV) stake by 1.9% in Q3 2026, selling an estimated $39.2K and leaving 7,816 shares worth $2.04M. The position accounts for 0.83% of the portfolio, ranked #41.

InvesTrust first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 2,139 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • InvesTrust held 7,816 shares of AbbVie worth $2.04M as of Q3 2026.
  • InvesTrust sold 153 AbbVie shares in Q3 2026, an estimated $39.2K.
  • AbbVie made up 0.83% of InvesTrust's portfolio in Q3 2026, its #41 holding.
  • InvesTrust first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 2,139 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on InvesTrust's 13F filing for Q3 2026, filed 14 Oct 2026.